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The clinical demand for neural stem cells drives the need for a reproducible method used 
to generate a large quantity of well-characterized cells to support regenerative therapies. 
Microcarriers are currently being used as a scaffold for stem cell culture to aid in this 
expansion process because they provide a larger surface area while also requiring fewer 
cell passages compared to monolayer culture. The main objective of this project was to 
investigate how human neural stem cell attachment, proliferation, and multipotency 
would respond to three-dimensional (3D) culture using peptide-coated microcarriers of 
varying diameters. In this study, multi-sized polystyrene microcarriers were fabricated 
 
 
 
 
using a vibration generator and solvent evaporation techniques in order to optimize the 
size distribution and homogeneity of the scaffold. Overall, the results indicated that when 
supplemented with a beneficial surface coating, the constructed microcarriers were 
successful at promoting stem cell attachment, growth, and viability without interference 
from surface curvature. This research will provide insight for further studies involving 
the feasibility of 3D culture on neuronal differentiation, the scale-up advantage of 
microcarriers, and clinical therapies.  
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1. INTRODUCTION 
 
 
Regenerative medicine is an interdisciplinary field that combines stem cell 
therapies and tissue engineering in order to treat disorders through safely restoring and 
repairing damaged organs1. Stem cell therapies are anticipated to treat a number of 
conditions including cancer, Parkinson’s disease, cardiac failure, neurological disorders, 
and Type 1 diabetes2. Even with the continuing advancements with stem cell research, 
there is still a set of drawbacks that can hinder the routine use of cell treatments. One 
major limitation for stem cell based therapies is the shear number of cells needed for 
effective transplantation doses. When considering an effective treatment for Parkinson’s 
disease, an individual transplantation should allow for the survival of 105 grafted 
dopaminergic neurons3. In a study involving autologous peripheral-blood stem cell 
transplantation, an effective dose for neutrophil recovery was between 5 x 106 and 8 x 106 
cells per kg of the patient4. Finally, for the clinical use of amniotic fluid stem cells 
(AFSCs), around 109 cells are needed for a patient weighing 70 kg5. With two 
dimensional (2D) cell culture allowing for only 105 cells/mL, about 10,000 mL of 
traditional cell suspension is needed for one transplantation dose5. Therefore, designing a 
scalable process for cell expansion independent of traditional cell culture procedures 
would be extremely beneficial when producing clinically relevant numbers for cell 
transplantation.  
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Typically in research laboratories cell lines are grown on flat surfaces, including 
flasks and plates. Although 2D cell culture is widely accepted, it does not fully represent 
the natural environment of cells within biological structures such as tissues and organs. 
Cells that make up these three-dimensional (3D) structures form a multifaceted 
biochemical and mechanical network through cell-to-cell interactions as well as 
connections to the extracellular matrix (ECM)6,7. Integrin receptors located on the cell’s 
surface allow the cells to link to the ECM, providing not only mechanical support but 
also an avenue for communication for important physiological cues involving cell 
growth, survival, organization, migration, and differentiation6,8. The geometry of flat 
substrates reduces the possibility of cells forming these multidimensional networks, so 
there needs to be a bridge between the traditional in vitro cell culture experiments and in 
vivo studies.  
Growing cells three dimensionally in vitro has its advantages for multiple 
applications including cell expansion, drug discovery, and cancer research because it 
allows cells to grow in an environment that is closer to in vivo testing9. Using 3D cell 
culture systems gives a model prior to in vivo models to overcome the limitations of 2D 
cell culture, which can be extremely beneficial since animal studies are typically costly as 
well as practically and ethically difficult 10,11. In addition to the geometrical differences 
between 2D and 3D cell culture systems, when considering cell expansion, monolayer 
cell culture in petri dishes or flasks is limited by surface area, labor intensive, difficult to 
scale-up, and prone to contamination5. 2D static culture systems are suitable for small-
scale projects but when considering the enormous quantity of stem cells needed for 
effective therapies there needs to be a more efficient way to increase scalability.  
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There are various methods of 3D cell culture systems that have been used in 
literature, ranging from cell spheroid formation to scaffold-based approaches.  These 
methods are outlined in Table 1.2, including their advantages and disadvantages. 
Originally spontaneous spheroid formation, such as forced-floating, hanging drop, and 
spinner flask methods, were used to monitor 3D cell growth and now various scaffold 
options are gaining popularity10. Cell spheroids allow for greater cell scalability when 
compared with monolayer culture and can mimic the stem cells’ native 
microenvironment by cell-cell and cell-ECM connections3. However, because of the cell-
to-cell contacts within the spheroid, spontaneous differentiation can occur and there can 
be cell death in the center of the sphere when the diameter becomes too large3.  This will 
require dissociation and re-aggregation steps throughout the cell expansion process to 
prevent agglomeration, adding additional labor and complexity of this 3D cell culture 
system3. 
Scaffolds are mainly used for clinical applications and 3D laboratory modeling, 
both of which have their own set of requirements. Clinical applications of scaffolds 
consist of creating practical implants that not only maintain tissue function but can also 
be metabolized into the body without creating an adverse reaction while in vitro models 
are used to improve the knowledge of cell biology and tissue physiology by mimicking 
the 3D nature of the body12. Important parameters are taken into consideration when 
creating scaffolds including porosity, elasticity, biocompatibility, mechanical stability, 
support of cell attachment, and diffusion of nutrients and waste in and out of the 
scaffold13,14. These aforementioned properties can be adjusted depending on the 
technique used during the fabrication process. It is also common to include ECM 
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proteins, such as laminin or collagen, to 3D cell culture systems in order to promote the 
cell-to-ECM connections characteristic of naturally occurring three-dimensional 
structures. When considering 3D scaffolds for cellular expansion, fibers, hydrogels, and 
microcarriers were further explored.  
Fibrous scaffolds are manufactured using electrospinning, self-assembly, or phase 
separation methods with electrospun scaffolds being the most widely studied technique 
for various applications15. Fibers created by electrospinning are done so by forcing a 
polymer solution through a syringe that is connected to a voltage source, charging the 
solution16. When the electrostatic force overcomes the surface tension of the liquid, a 
polymer jet stream is produced from the top of the syringe that then travels and dries in 
flight to the ground collector16. Electrospinning has the capacity of adjusting the size of 
the nanofibers within the scaffold, ranging from 100-500 nm, which is a major advantage 
because the fabricated fibers closely mimic the size of fibrous proteins found in the ECM, 
giving cells an environment that is similar to naturally occurring structures16,17. The 
increase in surface area-to-volume ratio as well as the microporous nature of fibrous 
scaffolds allows for an increase in cell attachment, migration, proliferation, and 
differentiation, which are very important when considering stem cell expansion for cell 
transplantation applications15,17. However, fibrous scaffolds are limited to their thickness 
and small pore size, which can prevent cell migration into the scaffold17. Alterations to 
fabrication techniques have been used to overcome these limitations, such as using 
ultrasonification in order to increase pore size to 10 microns or larger to allow for a 
greater cell infiltration17. Use of multilayer electrospinning has also help improve the 
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thickness in order to make the scaffold more 3D in nature as well increase the surface 
area for cell attachment17.  
Hydrogels are a water-swollen, cross-linked network of polymers that are used for 
cell culture because they mimic extracellular matrices, are mechanically similar to most 
soft tissues, and can support cell adhesion and growth18. There are number of fabrication 
methods that are used to adjust the internal structure of hydrogels, including free radical 
polymerization and crosslinking19. Hydrogels can be fabricated using synthetic polymers 
or naturally derived materials. The benefit of using synthetic materials is that the physical 
properties of the hydrogels can more easily be controlled, such as crosslinking densities 
and stiffness, while naturally derived materials, including collagen and fibrin, aid in 
biocompatibility and cell integration of the scaffold20. Even though hydrogels are 
extremely promising when considering cell culture, they do have their own set of 
fallbacks. Similar to fibrous scaffold, hydrogels can have minimal cell penetration within 
the scaffold due to the production of small pores during fabrication. Once again this will 
not allow cells to grow on the full surface area available. A second limitation to 
hydrogels is that it can be challenging when removing the cells embedded within the 
scaffold. Detaching cells within the hydrogel can be done by typical mechanical or 
enzymatic methods, however it takes great care in order to maintain integrity of 
intracellular components as well as produce sufficient cell yields18. It is vital to retrieve 
as many cells as possible when using hydrogels for cell expansion so this limitation can 
be a major downfall for the proposed application.  
Microcarrier cell culture systems (used interchangeably with microspheres and 
microbeads) have been used for research purposes since the 1960’s for various 
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applications21. Modified microcarriers were used to expand human embryonic cells and 
to see the effect of cryopreservation on cells adherent to microcarriers, aggregations of 
microcarrier-based systems were designed to produce microtissues, and research was 
done on porous microcarriers seeded with stem cells to see the effect on tissue 
regeneration22,23,24.  Because the growth of adherent cells is limited to area, the geometry 
of this scaffold provides a higher surface area-to-volume ratio in comparison to 
monolayer cell culture, allowing for increased productions and less physical space 
needed25. Microcarriers allow for less cell aggregation and death when compared to cell 
spheroid formation due to the fact that cells are grown on a monolayer on the scaffold 
surface when using nonporous options, allowing for more nutrient and waste diffusion3. 
Even though microspheres are advantageous over monolayer and cell spheroid culture, it 
does require more material and equipment cost during the fabrication process. Also, there 
are certain fabrication techniques that could prevent the scaffold from being free-floating, 
which would negate the benefit of there being an increase in area since the entirety of the 
surface would not be available for cell attachment and growth.  
This study focuses on fabricating and testing microcarriers of various diameters to 
observe if size and curvature have any effect on attachment, metabolic activity, and 
differentiation of stem cells. There has been successful studies testing different materials 
and coatings of microcarriers but they tend to focus on one size range of fabricated or 
commercially bought spheres when conducting cell culture experiments23,26–28. Also, 
research has been conducted using microcarriers as avenues for cell expansion for various 
cell lines, outlined in Table 1.1. Even though they were able to use coated microcarriers 
to promote attachment and proliferation, there were still downfalls that need to be 
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addressed. For the Phillips et al. study, cells were able to attach and proliferate when 
grown on commercially available polystyrene beads, however, the final cell densities 
were lower than what were previously reported, 5 x 105 cells/ml compared to 1.9-3.5 
x106 cells/mL, which is hypothesized to be caused by a difference in size of microcarriers 
between the two studies29. Heathman et al. showed that even though the microcarriers 
were again successful at promoting a fold- increase in cell quantity, the growth rate 
decreased during the second half of the cell culture experiment, showing that the 
agglomeration of the microcarriers could limit the effective surface area available for 
expansion30. This research was established to attempt to optimize these problems in past 
studies and design an adjustable fabrication system to create multi-sized, homogeneous 
microcarriers in order to assess the effects of geometry on expanding stem cells for the 
purposed of advancing stem cell therapies. 
Table 1.1 Various microcarrier-based systems for cell expansion 
Microcarrier-Based 
System 
Cell Line Tested Expansion (cells/ml) Ref. 
Trimethylamine-coated Hillex 
II polystyrene beads 
(diameter=160-200 µm) 
Mouse embryonic stem 
cells 
5 x 105 after 5 days (3-fold 
increase) 
29 
Fibronectin-coated, non-porous 
plastic microcarriers (diameter 
= 160-200 µm) 
Human mesenchymal 
stem cells  
3.01x105 after 6 days (10-fold 
increase) 
30 
Collagen-coated, microporous 
Cytodex-1 microcarriers under 
stirred conditions (diameter 
=147-248 µm) 
Sertoli cells 4.5 x 105 after 6 days (22.7 fold 
increase) 
31 
Poly-e-caprolactone 
microcarriers coated with 
vitronectin or laminin 
(diameter = 148-172 µm) 
Human embryonic stem 
cells  
Vitronectin: 1.7 x 106 after 7 
days (5-7 fold increase) 
 
Laminin: 1.1 x 106 after 7 days 
(5-7 fold increase)  
32 
Cellulose DE-53 cylindrical 
microcarriers coated with 
Matrigel under stirred 
conditions (diameter = 37 µm) 
Human induced 
pluripotent stem cells 
6.2 x 106 after 7 days (20-fold 
increase)  
33 
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Microcarriers can be either fabricated in-house or bought for research use. Some 
commercially available microcarriers are Cytodex (GE Healthcare), Cultispher-G 
(Percell), and Hillex II (SoloHill), which are proven to be successful in 3D cell 
culture28,34,35.  In order to produce microspheres in-house there are a number of methods 
that can be used including solvent evaporation, phase separation, and spray drying.  
Solvent evaporation is one of the most commonly used methods, which involves 
creating an emulsion between an oil component and a water component. This can either 
be done as a single emulsion (i.e. oil-in-water, water-in-oil, or oil-in-oil) or a double 
emulsion (i.e. water-in-oil-in-water).  The material, usually a polymer, forms an oil 
solution by dissolving the polymer particles in an organic solvent such as 
dichloromethane, acetone, or methylene chloride36. This polymer solution then creates an 
emulsion by mixing it with the water component that contains a surfactant, such as poly 
(vinyl) alcohol, that stabilizes the emulsion and prevents conglomeration of microcarriers 
once they are formed in the aqueous solution36. This emulsion is then mixed continuously 
until the solvent has evaporated from the microcarriers and a solid sphere is left37.  
Coacervation, or phase separation, is a process where two liquid phases are used 
in order to produce microspheres. The first liquid phase is a polymer-rich solution (the 
coacervate) that is incorporated with a second more dilute polymer solution, which 
decreases the polymer’s solubility38. The key to this technique for microsphere 
fabrication is that the two solutions are oppositely charged and immiscible, so when they 
are mixed together the separation of phases is induced, creating spheres39. A magnetic 
stirring system is used at appropriate speeds in order to prevent the microcarriers from 
attaching to one another and forming agglomerations. The formed spheres are hardened 
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by pouring the mixture into a non-solvent, counter ion solution before washing and 
drying36.  
The spray drying technique is used for the fabrication of porous and smaller 
microcarriers with a size range of 1-100 microns depending on the specifications of the 
nozzle attachment36. The polymer chosen for the microcarriers is dissolved in an organic 
solvent and then used with a laboratory spray-dryer. Spray-dryers include a spray nozzle, 
an aspirator to provide hot air, a drying chamber, and an area for collecting the dried 
particles40. Within the drying chamber, the polymer solution is sprayed out of the nozzle, 
producing a fine mist once mixed with the hot gas.  Using these commercially available 
spray dryers, the solvent within the microspheres is immediately evaporated out, and the 
dried microcarriers are then collected by a filter or cyclone36.  
For this study, polystyrene has been used to fabricate microcarriers for cell 
expansion experiments using a variation of the solvent evaporation emulsion method. A 
vibration generator was used in conjunction with a syringe pump in order to create the 
oil-in-water emulsion between a polystyrene solution and a poly(vinyl) alcohol solution. 
Changing the frequency of the vibration generator that was used in the fabrication setup 
was a crucial step when producing different sizes of microcarriers. Traditionally, 
polystyrene is used in cell culture vessels because it can easily be sterilized by irradiation, 
has great optical clarity, and is easily moldable into various sizes of flasks, plates, and 
dishes41. In order for cell attachment proteins to adhere and spread more effectively on 
the polystyrene, the surface is modified to change its properties from hydrophobic to 
hydrophilic41. Briefly, this done by either corona discharge or gas-plasma, which causes 
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oxygen ions to oxidize and graft onto the surface exposed for treatment, leaving a 
hydrophilic surface that becomes negatively charged with the addition of media41.  
Because polystyrene flasks go through a treatment process to aid in cell 
attachment, it was hypothesized that the polystyrene microspheres should also undergo a 
treatment process to increase adhesion as well. When certain cell lines are grown in 
adherent 2D cell culture, it is required that the surface is treated with a substrate such as 
poly-L-ornithine, laminin, fibronectin, or Matrigel to promote attachment, proliferation, 
and spreading42. Without this coating the cells will not attach to the polystyrene 
cultureware.  For this particular study, a previously established peptide solution was used 
to promote adherent culture on the polystyrene microcarriers. This peptide covalently 
links to the polystyrene surface and leaves a cell attachment domain available. Most cell 
lines share a common cell adhesion domain, therefore using this peptide can be 
applicable for more a multitude of cell types. This is extremely beneficial because the 
microcarrier-based cell culture system established in this study can be generalize for the 
expansion of many different cell types.  
Neural stem cells (NSCs) were used as an initial model for the microcarrier 
system developed in this project for cell expansion.  Human NSCs are self-renewing and 
multipotential stem cells, meaning they can divide indefinitely into more cells that are 
then able to differentiate into all the major cells that make up the adult CNS (neurons, 
astrocytes, and oligodendrocytes). An ideal treatment for injured brain tissue is to replace 
the damaged cells with healthy neural cells to restore functionality of the CNS43. 
However, this comes with it own set of disadvantages including an access to a specific 
amount of cells for an effective transplantation dose, immunological rejection, and lack 
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of efficacy44. Even though there is still room to grow when it comes to improving 
methods for CNS repair, optimally expanding NSCs to increase the number of viable 
cells for potential treatments is an important step in the right direction. Using 
microcarriers for this purpose is beneficial because the increase in surface area due to the 
geometry of spheres allows for more area for cells to grow and later differentiate into 
neurons and glial cells.  
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Table 1.2: Advantages and disadvantages of various systems for 3D cell culture 
Method Description Advantages Disadvantages 
Forced-floating45 Culture wells are 
coated to prevent 
attachment, causing 
the cells to float and 
later form spheroids 
by cell-to-cell contact 
Simple, reproducible, 
size is easily 
adjustable 
Extra time/work is 
required for coatings, 
increase in cost by 
buying low-adhesion 
plates 
Hanging drop45 Small amounts of cell 
suspension (~20 µL) 
are pipetted onto a 
tray, which is then 
inverted, forming 
hanging drops where 
cells form spheroids at 
the tip of the drop 
Simple, reproducible, 
low variability in sizes 
Cell culture does not 
allow for volumes 
larger than 50 µL due 
to weight of the drop 
overcoming surface 
tension. It is also 
difficult to change 
media without 
disturbing the drop 
Agitation-based 
approaches: Spinner 
flask bioreactors45 
Spinner flasks form 
spheroids by 
continuously mixing 
the cell suspension 
with a stirring bar  
Simple, large yields of 
spheroids, easy 
change of media  
Motion causes shear 
force on the cells 
which adversely 
affects physiology, 
broad range of 
spheroid sizes 
Agitation-based 
approaches: 
Rotational culture 
systems45 
Spheroids are formed 
by constantly rotating 
the culture system 
about a horizontal 
axis, preventing the 
cells from attaching to 
the system walls 
Low shear force, 
simple, large 
spheroids yields, easy 
change of media 
Requires specialized 
equipment, size of 
spheroids varies 
Microfluidic cell 
culture platforms45  
Microplates are 
separated into units 
including inlet/outlet 
wells and a culture 
chamber (CC). The 
cells are immobilized 
within the CC, 
allowing them to form 
spheroids 
Multi-dimensional 
imaging, minimizing 
reagent volumes 
Retrieval and 
characterization of 
spheroids can be 
difficult 
Scaffolds45 3D structures, such as 
hydrogels and 
microcarriers, offer 
support for cell 
growth by use of 
fibers, pores, and an 
increase in area 
Easily manipulated 
with cell adhesion 
molecules, growth 
factors, or fabrication 
techniques 
Requirement of 
specialized materials 
and equipment which 
can increase cost, 
retrieval of cells from 
scaffolds can be 
difficult 
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2. MATERIALS AND METHODS 
 
 
 
 
2.1 Materials 
Polystyrene (MW~ 350,000), poly(vinyl alcohol) (average MW~30,000-70,000), 
and goat anti-rabbit IgG antibody were purchased from Sigma-Aldrich (St. Louis, MO). 
Dichloromethane (DCM) was obtained from Fisher Scientific (Waltham, Massachusetts). 
Accutase was purchased from Innovative Cell Technologies (San Diego, CA). Alexa 
Fluor® 488 dye and 4’, 6-Diamidino-2-Phenylinole, Dihydrochloride (DAPI) were 
purchased from Molecular Probes (Eugene, OR). Recombinant human fibroblast growth 
factor-2 (FGF-2) and epidermal growth factor (EGF) were obtained from Peprotech 
(Rocky Hill, NJ). Mouse anti-βIII tubulin mAb antibody was purchased from Promega 
(Madison, WI). Goat anti-mouse IgG1 antibody was purchased from Invitrogen  
(Rockford, IL). Rabbit anti-GFAP antibody was obtained from Abcam (Cambridge, MA).  
 
2.2 Microcarrier Fabrication 
 
A 15% (wt./vol.) polystyrene (PS) solution was produced by dissolving PS 
particles into dichloromethane (DCM), an organic solvent not miscible with water. This 
was done by using a motorized mixer over several hours to allow for a homogenous 
mixture (Scientific Products, Evanston, IL). A 0.5% (wt./vol. in PBS) poly(vinyl) alcohol 
(PVA) solution was produced by dissolving PVA in distilled water using a magnetic 
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stirrer while heated to 105°C and then filtered to remove any debris or particles that were 
not dissolved.   
The fabrication set-up is shown in Figure 2.1A. The PS solution was drawn into a 
3 mL syringe (BD, Franklin Lakes, NJ) that was topped with a 23 gauge, 1-inch metal 
syringe tip (Jensen Global Inc., Santa Barbara, CA). The syringe was securely placed in 
the syringe pump (World Precision Instruments, Sarasota, FL) and the pump was placed 
vertically on an adjustable platform so that the syringe tip was pointing directly into a 
large glass petri dish that was then filled with 200 mL of the 0.5% PVA solution (Figure 
2.1A). The syringe was placed underneath the water level to prevent a polymer film 
forming on top of the PVA solution (Figure 2.1B). The vibration generator (3B Scientific, 
Hamburg, Germany) was placed behind the glass petri dish so that the vibrating arm was 
parallel above the dish, intersecting with the syringe tip.  
 
 
 
 
 
 
 
 
Figure 2.1: A) Complete microcarrier fabrication system including the vibration 
generator, syringe pump, polystyrene solution within the syringe, and poly(vinyl)  
alcohol solution within the glass petri dish. B) Close up of the fabrication system. 
A B 
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The syringe pump began pumping at 150 µL/min. Once the air bubbles were 
released from the syringe, large microspheres began to form and drop into the PVA 
solution due to an oil-in-water emulsion. A smaller plastic petri dish covered in 
aluminum foil was placed in the glass petri dish to catch the first several microspheres 
produced before the vibrations began. Once the larger microspheres were formed 
regularly, the vibration generator was turned on. The parameters for the vibration 
generator were as followed: amplitude of 10V, triangle wave, and the frequency varied 
from 18 Hertz to 24 Hertz. When smaller microspheres were wanted, a higher frequency 
was used and when larger microspheres were needed a lower frequency was used. After 
several microspheres were produced, the smaller plastic petri dish was removed and the 
microspheres began to coat the bottom of the glass petri dish until the 3 mL of PS 
solution was completely depleted from the syringe, taking about 30 minutes. Each 
vibration generator was used for 30 minutes followed by a 3-hour rest to prevent 
overheating. Two vibration generators were used to maximize microsphere fabrication. 
After the fabrication process, the formed microspheres were allowed to sit in the PVA 
solution for 2 to 3 days so that the solvent would fully evaporate and the microspheres 
would harden and become opaque.  
 
2.3 Size Separation   
After fabrication and hardening, the microspheres underwent a sieving process to 
separate them into specific size ranges using different sized test sieves from VWR 
(Radnor, PA). The glass petri dishes containing the PVA solution and hardened 
microspheres were poured into a 125-micron sieve and those particles that were smaller 
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than 125 microns were forced through the sieve by using a plastic squeeze wash bottle 
filled with distilled water. The microspheres remaining in the 125-micron sieve were then 
transferred to the 212-micron sieve and the samples smaller than 212 microns were 
forced through into a beaker using the wash bottle, forming the first size range of 125-
212 microns. The aforementioned sieving process was continued until the following size 
ranges were formed: 125-212 microns, 212-300 microns, 300-355 microns, 355-425 
microns, and 425-500 microns. The groups were sieved multiple times to remove any 
spheres that did not belong in that range. The microspheres were then stored in 50 mL 
conical tubes in PBS until SEM imaging or cell culture experiments.  
 
2.4 SEM Imaging of Microcarriers 
Scanning electron microscope (SEM) imaging was used in order determine the 
size and 3D topography of the microcarriers. A small amount of microcarriers from each 
size group were freeze-dried, or lyophilized, in order to prepare the samples for imaging. 
Briefly, the microspheres were frozen in -80°C and then placed in the Labconco 
FreeZone® 4.5 Liter Freeze Dry System (Kansas City, MO) overnight. Once fully dried, 
the microcarriers were securely added to a mount using double-sided tape and then 
covered with a thin layer of gold making the sample conductive, attracting the electrons 
within the SEM. The images were obtained using JEOL LV-5610 SEM (Toyko, Japan). 
 
2.5 Human Neural Stem Cell Culture 
Human neural stem cells (hNSCs) derived from the ventral midbrain region of the 
fetal brain were acquired from Millipore (Billerica, MA). These specific hNSCs are a 
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multipotent human neural progenitor stem cell line that has the ability to differentiate into 
neurons and glial cells once growth factors are removed from the culture media. hNSCs 
are self-renewing and immortalized by retroviral transduction with the v-myc oncogene, 
allowing them to successfully go through numerous passages while maintaining their 
undifferentiated characteristics. When grown on monolayer plates, it is expected that 
100% of the NSCs show expression for nestin before differentiation is induced, which is 
the marker for neural stem cells46,47. When considering undifferentiated NSCs, there 
should be few or no spontaneous differentiated cells that show expression of beta-III 
tubulin, the marker for neurons, and GFAP, the marker for astrocytes46,47. Seven days 
after the induction of differentiation, it is normal for there to be a larger percentage of 
positive staining for beta-III tubulin and a smaller percentage of the cells showing 
expression for GFAP and O1, the surface marker for oligodendrocytes46.  
An in-house produced peptide mixture (0.04 mg/ml) was used to coat tissue 
culture flasks for up to 4 hours before cell seeding. The hNSCs were maintained in 
DMEM/F12 (1:1) medium (Sigma-Aldrich) with added FGF-2 (20 ng/ml) and EGF (20 
ng/ml).  2D adherent hNSCs were incubated at 37° C under 5% CO! until they reached 
80%-90% confluent.  
 
2.6 Microcarrier Cell Culture 
After several serial sievings, each size range produced from the microsphere 
fabrication process (125-212 micron, 212-300 micron, 300-355 micron, 355-425 micron, 
and 425-500 micron) were separated into two smaller tubes in preparation for surface 
coatings. The PBS was removed from each tube and the microspheres were washed 
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multiple times with 75% ethanol to sterilize them prior to cell culture experiments. For 
the uncoated microcarriers, the samples were washed three times with PBS and then 
transferred to suspension 48 well culture plates (Sigma-Aldrich, St. Louis, MO) and 
covered with hNSC media. For the peptide-coated microcarriers, the samples were first 
coated with 0.01% (wt./vol. in PBS) PVAVS for 10 minutes and then coated with the 
same peptide solution used in regular 2D culture flasks for up to 4 hours and then placed 
in the suspension 48 well plates. Suspension plates were used in the experiments to 
prevent cell attachment to the well surface and promote attachment to the microcarriers. 
For both the uncoated and peptide coated microcarriers, the same volume of spheres were 
added to each well to coat the bottom of the surface. In addition to the microcarrier trials, 
parallel uncoated and peptide-coated 2D samples were run as well. The well plate 
configuration is shown in Figure 2.2. The hNSCs grown in flasks were rinsed and then 
incubated with Accutase for 5 min at 37°C to detach the cells from the surface and form a 
single-cell suspension. After the cell suspension was centrifuged at 220 rcf for 5 minutes, 
the supernatant was removed and the cells were resuspended in 1 mL of hNSC media to 
prepare for cell counting using the hemocytometer-based trypan blue dye method. Using 
this method, it was possible to obtain an accurate count of hNSCs while also obtaining 
the different percentages of live and dead cells. Both 2D and 3D sample groups were 
seeded with 40,000 cells/well and the media was changed every other day until Day 7. 
When necessary, hNSCs grown on microcarriers were dissociated from the surface using 
the Accustase protocol previously mentioned.  
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Figure 2.2: Schematic of the microcarrier cell culture experiment. 
 
 
 
2.7 Metabolic Activity Analysis 
Metabolic activity of the hNSCs were analyzed using the alamarBlue® Assay 
(Invitrogen). The alamarBlue® Assay is a growth indicator that uses an oxidation-
reduction reaction that gives both fluorescent and colorimetric information on the 
metabolic activity of the samples. In brief, active cells have the ability to continuously 
reduce nonfluorescent resaurin, the active ingredient in alamarBlue®, into fluorescent 
resorufin. The more metabolically active cells within the sample, the greater the percent 
reduction of resazurin and the color of the media will change from blue to bright pink.  In 
this study, the alamarBlue® Assay was used on Day 7 to analyze the metabolic activity 
of the different samples. Media was removed from all wells, the alamarBlue®/media 
mixture (1 mL alamarBlue®: 9 mL hNSC media) was added to cover (350 µL), and the 
well plate was place in the incubator for 4 hours. A control well was included which was 
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an empty well with no cells filled with the AlamarBlue®/media mixture. After 4 hours, 
100 µL of the dye was added in triplicate to a 96 well plate from each study group, 
including the alamarBlue® control. The 96 well plate was read in the Snergy H1 Multi-
Mode Reader (BioTek Instruments, Inc., Winoski, VT) at two wavelengths: 570 nm and 
600 nm. The data was then analyzed using the equation provided below to determine 
percent reduced in each study group. 
%  Reduced =    ε!" λ!Aλ! − ε!" λ!Aλ!ε!"# λ!A!λ! − ε!"# λ!A′λ!   x  100 
With the following parameters: ε!" = molar  extinction  coefficient  of  alamarBlue®  oxidized  form, ε!"# = molar  extinction  coefficient  of  alamarBlue®  reduced  form, A = absorbance  of  test  wells, A! = absorbance  of  negative  control  wells, λ! =570  nm, λ! = 600  nm, ε!"λ! = 80,586, ε!"λ! = 117,216, ε!"#λ! = 155,677, and ε!"#λ! = 14,652. 
 
2.8 Immunofluorescence 
After the AlamarBlue® Assay analysis, the cells were washed with PBS, fixed 
with 4% (wt./vol. in PBS) paraformaldehyde (PFA) and then permeabilized with 0.2% 
(vol./vol. in PBS) Triton-X 100 for an additional 30 minutes. For cell attachment studies, 
F-actin was stained with Alexa Fluor® 488 dye (5 µL dye: 200 µL PBS) for 2 hours. 
After 2 hours, the nuclei were then counterstained with DAPI (1 µL dye: 1000 µL PBS) 
for 10 minutes. For differentiation studies, the cells were fixed and permeabilized as 
mentioned previously. The cells were then blocked with 10% (vol./vol.) goat serum in 
PBS for 30 minutes. The samples were sequentially incubated with the primary 
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antibodies for neurons and glial cells overnight at 4° C and then incubated with the 
secondary antibodies for 1 hour at room temperature. The nuclei were counterstained 
with DAPI for 10 minutes. For neuronal staining, the primary antibody used was mouse 
anti-βIII tubulin mAb (G7121) and the secondary antibody used was goat anti-mouse 
IgG1 (A-21121, 1:400). For glial staining, the primary antibody used was rabbit anti-
GFAP (ab7260) and the secondary antibody goat anti-rabbit IgG TRITC (T6778, 1:400). 
To characterize the neural stem cells, nestin colocalization was confirmed by using the 
primary antibody Mouse Anti-Nestin Antibody (Millipore, MAB5326, 1:100) and the 
secondary antibody goat anti-mouse Cy2-conjugated Affinipure, IgG/FCγ1 (Jackson 
ImmunoResearch, 15100). The groups were finally washed three times with PBS and 
then covered in a 0.1% sodium azide solution in order to preserve the samples. 
Microcarriers were imaged over various time periods using an Olympus CKX41 culture 
microscope (Melville, NY) to observe cell attachment. Fluorescent images of the stained 
undifferentiated and differentiated hNSCs were acquired with an Olympus IX81 confocal 
microscope.  
 
2.9 Statistical Analysis 
Statistical analysis was performed in MATLAB using one-way analysis of 
variance (ANOVA) followed by Tukey’s post-tests. A probability (p) value of < 0.05 was 
considered statistically significant. The data is shown as mean ± standard deviation.  
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3. RESULTS 
 
 
 
 
3.1 Microcarrier Fabrication 
Polystyrene microspheres were fabricated using a variation of the oil-in-water 
emulsion technique through a programmable vibration generator in combination with a 
syringe pump. The overall goal of the fabrication process was to optimize the size 
distribution and homogeneity of the scaffold. The factors controlling the size of the 
microcarriers included concentration of the polystyrene solution, thickness of the syringe 
tip, rate of the syringe pump, and vibration generator parameters. The most successful 
factor when producing various sizes of microcarriers was the parameters of the vibration 
generator within the fabrication system, mainly the frequency of the vibrating arm. When 
the frequency of the arm was lower (17-19 Hz), the microcarriers formed were larger and 
more uniform (Figure 3.1A) and when the frequency was higher (19+Hz) the spheres 
were less homogeneous and smaller (Figure 3.1B).  
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Figure 3.1: The diameter of the polystyrene microcarriers decreased and became 
less homogeneous when the frequency of the vibrating arm increased. A) 
Microcarriers when the vibrating arm was set to 18 Hz. B) Microcarriers produced 
when the vibrating arm was set to 22 Hz.  
 
3.2 Characterization of Polystyrene Microcarriers  
 
After fabrication and hardening, the microspheres underwent a multi-step sieving 
process in order to separate the samples into specific size spectrums. From this process, 
five different sizes ranges were produced which are shown in Table 3.1.  A small amount 
of microspheres were taken out of the stock batches and freeze-dried for SEM imaging in 
order to give a more accurate determination of the size and topography (Figure 3.2). For 
each size range, multiple SEM images were taken and 100 microspheres were analyzed. 
The images were opened in ImageJ, the scale was set using the legend bar given on the 
figure, and the area of the spheres were measured using the circle tool. This area 
measurement was then converted to diameter dimensions in Excel, giving the average 
diameter data shown in Table 3.1. 
 
 
 Size Range (um) Average Diameter (um) 
Size 1 (S1) 125-212 165.41± 21.80 
Size 2 (S2) 212-300 256.27  ±  20.46 
Size 3 (S3) 300-355 317.33  ±  26.65 
Size 4 (S4) 355-425 407.52 ± 26.36 
Size 5 (S5) 425-500 470.39 ± 35.42 
 
 
 
 
 
 
 
Table 3.1: Size characterization of fabricated microcarriers 
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Figure 3.2: Microcarriers were produced using a vibration generator in conjunction 
with a syringe pump in order to create an oil-in-water emulsion between the 
polystyrene solution and the poly(vinyl) alcohol solution and then separated using 
various sized sieves. (A) Size 1 (125-212 microns), (B) Size 2 (212-300 microns), (C) 
Size 3 (300-355 microns), (D) Size 4 (355-425 microns), (E) Size 5 (425-500 microns).  
  
 In the cell culture experiments, roughly the same volume of microcarriers for each 
size spectrum was used for each well (~0.12 cm!), assuming random sphere packing. 
The total surface area and volume of one microcarrier was calculated with the formulas 𝑉! = !!𝜋𝑟! and 𝑆𝐴! = 4𝜋𝑟!. The total amount of spheres per well for each sample size 
was then determined by dividing the total volume per well by the volume of one sphere. 
This was used to determine the surface area-to-volume ratio for each size spectrum, 
shown in Figure 3.3. Size 1 (125-212 microns) had the highest ratio while Size 5 (425-
500 microns) had the lowest ratio, which was expected because the smaller the diameter 
the larger the SA-to-V ratio.  
 
C B A 
D E 
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Figure 3.3: As the diameter of the microcarrier increased, the surface area-to-
volume ratio decreased. Size 1 (d=165.41± 21.80 microns) has the highest SA-to-V 
ratio (369.09 𝒄𝒎!𝟏) while Size 5 (d=470.39 ± 35.42 microns) has the lowest SA-to-V 
ratio (128.25 𝒄𝒎!𝟏). 
 
3.3 Stem Cell Attachment to Microcarriers 
 
Both optical and confocal imaging were used in order to visualize the ability of 
hNSCs to attach and remained attached to the peptide-coated microcarriers while also not 
adhering to the surface of the well plate. Immediately after cell seeding, the cells are seen 
floating in the culture media (Figure 3.4 A, D, G, J, M) and by Day 2 the cells have 
attached to the surface of the microcarriers and formed junctions between the spheres 
(Figure 3.4 B, E, H, K, N).  The culture experiment was continued for 7 days before the 
cells were fixed and then stained with DAPI (nucleus) and phalloidin (actin), further 
showing stem cell attachment (Figure 3.4 C, F, I, L, O). By Day 7, the cells within the 
wells of the uncoated microcarriers had been washed away by changing of media and 
there was minimal attachment to the surface of the spheres (Figure 3.5).  
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After confocal imaging, the DAPI images (Figure 3.6 A-F) of the peptide-coated 
2D and 3D samples, which respresent the hNSC nuclei, were analyzed in ImageJ to 
determine fluorscent intensity followed by cell count. Cell count was normalized by 
surface area available with that image, shown in Figure 3.6G. When seeding with the 
same density of hNSCs, the 2D and 3D samples resulted in similar cells per mm!, further 
showing that microcarriers are able to support cell attachment and growth..  
 
Figure 3.4: Peptide-coated microcarriers were able to promote human neural stem 
cell attachment to the surface of the spheres while in suspension well plates, which 
prevented cell attachment to the well surface. Size 1 (A-C), Size 2 (D-F), Size 3 (G-I), 
Size 4 (J-L), Size 5 (M-O). Optical images immediately after cell seeding (A, D, G, J, 
M) and 48 hours after seeding (B, E, H, K, N). Merged confocal images 7 days after 
the start of the experiment, with the nucleus stained with DAPI (blue) and actin 
stained with phalloidin (green) (C, F, I, L, O). All scale bars: 200 microns.  A B C 
D E 
Figure 3.5: Uncoated microspheres at Day 7. There was no significant stem cell 
attachment to Size 1 (A), Size 2 (B), Size 3 (C), Size 4 (D), or Size 5 (E). Scale bar: 
200 microns. 
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Figure 3.6: The nuclei of neural stem cells grown on a peptide-coated monolayer (A) 
as well as on the varying diameters of peptide-coated microcarriers (B-F) were 
stained with DAPI and then analyzed in ImageJ to determine the number of cells 
per area. The 2D and 3D samples were statistically similar when comparing 
cells/mm2, further showing that the microcarriers aided in the attachment and 
spreading of cells when there was a substrate coating. Scale bar: 100 microns.  
 
3.4 Metabolic Activity Analysis 
 
After 7 days in cell culture, the alamarBlue® Assay was performed in order to 
assess the cell viability of hNSCs grown in monolayer culture and on the polystyrene 
microcarriers. The higher the percent reduction of alamarBlue®, the more metabolically 
active cells within that well. For the five size ranges as well as the 2D control, there was 
both an uncoated sample group as well as a peptide-coated group. For each pair of 
samples, the uncoated group was statistically lower than the peptide-coated group (Figure 
3.7), giving evidence that a beneficial coating is necessary to promote cell adhesion for 
adherent neural stem cell culture. When comparing all the peptide-coated groups, there 
were similarities between the 2D and 3D samples (Figure 3.8), giving further evidence 
that the increase in area of the microcarriers promotes cell growth without hindrance 
from the surface curvature. However the 2D sample was statistically higher than S3-S5, 
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which could be due to loss of microcarriers and therefore loss of hNSCs during media 
renewal.  
 
 
 
 
 
 
Figure 3.7:  The alamarBlue® Assay was used to assess metabolic activity of the 
microcarrier cell culture experiments. The more metabolically active cells within the 
sample, the greater the percent reduction of resazurin, the active ingredient within 
alamarBlue®. For each microcarrier size as well as the 2D control, the uncoated 
sample component was statistically less when it came to percent reduction compared 
to its peptide-coated counterpart, showing the benefit of the peptide coating on cell 
adhesion.  
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Figure 3.8: When comparing the alamarBlue® Assay results for the 2D and 3D 
peptide-coated samples, a majority of the groups were statistically similar, showing 
that the coated microcarriers were able to promote cell attachment and growth 
while also allowing the cells to remain viable and metabolically active. * represents a 
significant difference compared to the 2D group and # represents a significant 
difference compared to the S1 group.  
  
3.5 Differentiation of Human Neural Stem Cells 
 
 Neural stem cells attached to peptide-coated microcarriers were grown in hNSC 
media without the addition of growth factors in order to induce neuron and glial cell 
differentiation. For this differentiation study, S1 (125-212 microns), S3 (300-355 
microns), and S5 (425-500 microns) were used. After 12 days, the multipotency of 
hNSCs grown in a three dimensional manner was confirmed by using antibody staining 
against specific proteins within neurons and glial cells (Figure 3.9). During this time, 
cells not only grew around the curvature of the microcarriers, but also formed junctions 
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of cell bodies in between the spheres (Figure 3.9 E, I, M), which was not possible during 
monolayer culture (Figure 3.9 A-D). 
  
  
 
Figure 3.9: Peptide-coated microcarriers were able to provide support for hNSC 
differentiation to neurons and glial cells after 12 days in differentiation media. 2D 
monolayer (A-D), Size 1 (125-212 micron) (E-H). Size 3 (300-355 microns) (I-L). Size 
5 (425-500 microns) (M-P). While in differentiation cell culture, neural cells began 
forming cellular masses in between microcarriers (E, I, M). Cell nuclei were stained 
with DAPI (blue), differentiated neurons were labeled with anti-Beta III tubulin 
antibodies (green, column 2), and differentiated glial cells were labeled with anti-
GFAP antibodies (red, column 3). Column 4 represents the merge of all three dyes.  
All scale bars: 100 microns.  
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4. DISCUSSION 
 
 
 
 
 
Pharmacological treatments of neurodegenerative disorders and neural injuries are 
available to relieve some symptoms for patients, however, a move intensive method is 
needed for long-term repair of the central nervous system48. In order to make positive 
strides towards successful therapies for degenerative diseases there needs to be a practical 
method to provide a large number of neural stem cells in a timely manner. Microcarriers 
are currently being used as a scaffold for adherent cell culture to aid in this expansion 
procedure because they provide a larger surface area per unit volume compared to 
monolayer culture. When considering cell expansion, a large surface area-to-volume ratio 
is advantageous because not only is there more area for cells to attach and proliferate, the 
microcarriers also take up less space25. Longer culture times, higher cell density and 
effective scalability are also beneficial when using three-dimensional scaffolds in 
comparison to normal flask culture.  
For this experimental study, multi-sized polystyrene microcarriers were produced 
using a vibration generator and solvent evaporation techniques in order to grow and 
expand human neural stem cells (hNSCs) in a three dimensional manner. The main 
objective of this project was to produce homogenous spheres of varying diameters to 
promote cell attachment, proliferation, and differentiation. Different combinations of 
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syringe gauge tips, syringe pump rates, and frequency of the vibration generator were 
used to determine how the size of the microcarriers would respond. The thicker syringe 
tips typically produced larger microcarriers while thinner syringe tips had a tendency to 
produce smaller spheres. Also the higher the frequencies (20 Hz and higher), the smaller 
and less homogenous the microspheres while larger and more consistent spheres were 
produced at lower frequencies (18 Hz and below). When it comes to particle size, the 
successful fabrication of microcarriers with varying diameters can be beneficial for 
different applications. Smaller spheres sizes have been used for smaller stirred flasks 
while larger microcarriers can be used in industrial-sized bioreactors for cell culture 
given their higher sedimentation rate due to a higher mass25. To further expand this study, 
the microcarrier fabrication system and materials can be modified so that the 
microcarriers are free floating within the media without the use of agitation, which can 
cause damaging shear force upon the cells. This will allow the entirety of the 
microsphere’s area to be available for cell attachment compared to when beads are 
coating the bottom of the culture plates. This can be adjusted by changing the 
combination of materials used during the fabrication process, such as using a base 
solution that is miscible with dichloromethane like acetic acid.  
Polystyrene was used in this study because of its optical clarity, biocompatibility, 
ease of molding into various structures, and customary use in a laboratory setting. In 
order to enhance cell adhesion to the polystyrene, the samples were coated with a peptide 
solution. This is advantageous in the long run because the cell attachment domain within 
the peptide sequence can be used to adhere various cell lines, making this process open 
for more than just NSC culture. Future studies will use different cell lines, such as human 
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induced pluripotent stem cells or human mesenchymal stem cells, to compare the 
expansion rates. The addition of a peptide coating on both the 2D monolayer samples as 
well as all five microsphere sizes proved successful in aiding cell attachment of neural 
stem cells 24 hours after cell seeding without the addition of agitation. The cells 
remained attached to the microcarriers for up to 7 days before fixing and staining. In 
order to amplify the study, staining against nestin can be used in future studies in order to 
fully characterize the neural stem cells that have attached the peptide-coated 
microcarriers. Typically when NSCs are grown in undifferentiated media in two 
dimensions, 100% of the cells stain positive for the nestin marker so it would be 
beneficial to compare this quantity to the percentage of cells expressing nestin when 
grown on peptide-coated microcarriers46,47. In addition, to verify the viability of the cells 
grown on the microcarriers, the LIVE/DEAD Viability Kit should be used, which uses 
green fluorescent SYTO 10 to stain live cells and red fluorescent ethidium homodimer-2 
to label dead cells. The more viable cells retrieved, the more applicable the microcarriers 
will be for stem cell therapies.   
Any uncoated samples showed minimal attachment of hNSCs through optical 
imaging, further proving the need for a favorable cell adhesion coating for the 
polystyrene microcarriers. Cells grown on the peptide-coated microcarriers maintained 
their metabolic activity and were comparable to peptide-coated 2D wells. In addition, any 
uncoated sample possessed a statistically lower amount of proliferation compared to their 
parallel peptide-coated groups. This is a positive outcome because it shows that when 
microcarriers are modified with an advantageous coating they are able to promote cell 
growth without the curvature of the spheres causing a negative effect. However, when 
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comparing certain peptide-coated microcarrier sizes to the 2D samples, there was some 
discrepancy between the percent reductions of alamarBlue®, showing that the monolayer 
culture had more metabolically active cells compared to the 3D culture when seeding 
with the same amount of cells. Even though the numbers were similar, the difference 
could be due to loss of microcarriers in cell culture during media renewal or 
agglomeration of microcarriers during cell growth. During future studies, this process 
will be optimized to prevent microcarrier and cell loss in order to get the most accurate 
metabolic activity data.  
In order for hNSCs to be used for future clinical studies involving CNS therapies, 
they need to maintain their differentiation abilities while undergoing this expansive 
process. In this study, hNSCs were able to differentiate into neurons and glial cells 
without any hindrance from surface coating or surface curvature when grown on the 
fabricated polystyrene microcarriers of varying diameters. Neurons are responsible for 
processing and transmitting information within the CNS while glial cells are responsible 
for supporting the functions of neurons, so the greater the number of hNSCs that are 
expanded through this process and then eventually differentiated in neurons and glial 
cells, the more useful this research will be to the end goal of successful neural cell 
transplantation49. To further analyze this differentiation experiment, future studies will 
include fluorescent-activated cell sorting, or FACS, to determine the percentage of cells 
that express neuron and astrocyte markers within the population of differentiated cells 
grown on the microcarriers. Typically for NSC culture, a larger portion of the 
differentiated cells show expression for beta-III tubulin, the marker for neurons and a 
smaller percentage of cells showed expression for GFAP, the marker for astrocytes46. So 
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to prove that microcarriers systems not only support but also have a positive effect on 
differentiation, is would expected that the percentage of expression for neurons and 
astrocytes would be similar or greater than what is typically seen in NSC cell culture.  
Also, a control group will be included where undifferentiated NSCs grown on 
microcarriers are stained against beta-III tubulin and GFAP to determine the baseline of 
neurons and astrocyte expression. In typical NSC culture, undifferentiated cells showed 
close to zero expression for beta-III tubulin and GFAP46,47.  
 During the differentiation experiments, the cells attached to the surface and 
spread around the curvature of the spheres as well as formed cellular masses through cell-
to-cell interactions, causing the microcarriers to began to agglomerate. This suggests that 
microcarriers allow cells to grow in a three dimensional manner as cellular bodies while 
also growing as a monolayer on the surface of the spheres, which is an advantage to 
traditional flat surfaces because it creates a more in-vivo like environment. However, the 
cell masses that begin to form in between microcarriers should be carefully watched 
because if the cell density becomes too high the transport of nutrients and waste will 
become inefficient and the hNSC may loss their natural abilities to proliferate and later 
differentiate.  
In order to continue to optimize this system, the polystyrene microcarriers should 
be used in larger vessels with varying seeding densities to see how long the scaffold can 
support stem cell growth. This study showed that 2D and 3D samples were consistent 
when it came to the amount of attachment and metabolically active cells once the 2D 
samples became confluent, however, it is expected for the 3D samples to have a higher 
cell quantity in the long-term due to the limited surface area of monolayer culture and the 
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increase of area in the microcarrier samples. When considering 100% confluency, an 
average yield is around 10!  cells/cm!. For a 48 well plate, which was used in this study, 
each 2D well is expected to yield about 80,000 cells. Moving forward, the 2D and 3D 
samples should be monitored after seeding with 80,000 cells to see the effect of the 
increase in area of the microcarriers. In an ideal setting, S1 (average surface area in this 
study (SAavg) = 34.8 cm2) will produce a cell yield of 3.5 x 106, S2 (SAavg= 22.6 cm2) will 
produce a cell quantity of 2.3 x 106, S3 (SAavg= 19.0 cm2) will produce a cell quantity of 
1.9 x 106, S4 (SAavg= 13.6 cm2) will produce a cell quantity of 1.4 x 106, and S5 (SAavg= 
11.8 cm2) will produce a cell quantity of 1.2 x 105, shown in Figure 3.10. Therefore, 
long-term studies are hypothesized to show the benefit of microcarrier-based systems 
over monolayer systems through an increase in cell quantities as well as show the benefit 
of using smaller diameter microcarriers due to the increase in surface area available for 
cell attachment and growth. 
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Figure 3.10: Hypothetical cell quantities for 2D and 3D samples once 100% 
confluency have been reached.  
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5. CONCLUSION 
 
 
 
 
 
In this study, homogenous polystyrene microcarriers were successfully produced 
using an oil-in-water emulsion and vibration generator in order to promote hNSC 
attachment, viability, and differentiation. The fabrication technique was optimized to 
produce microcarriers of varying diameters. These microcarriers provided a three-
dimensional environment for cell growth as well as an increase in surface area, both 
advantageous when compared to the traditional flat tissue culture plates and dishes. When 
supplemented with a beneficial peptide surface coating, cell attachment and proliferation 
was significantly amplified without any hindrance due to surface curvature. After 12 days 
of being cultured in differentiation media, the hNSCs attached to the microcarriers were 
effectively differentiated into neurons and glial cells, which is the ultimate goal for 
central nervous system injury treatments by cell transplantation. This research 
demonstrates the growing potential of microcarrier-based cell culture systems on future 
stem cell therapies through rapid cell expansion.  
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